Provided by Tiger Trade Technology Pte. Ltd.

Tenaya Therapeutics Inc

0.5700
+0.00821.46%
Post-market: 0.5693-0.0007-0.12%19:59 EST
Volume:2.67M
Turnover:1.49M
Market Cap:123.41M
PE:-0.76
High:0.5799
Open:0.5568
Low:0.5400
Close:0.5618
52wk High:2.35
52wk Low:0.3600
Shares:216.51M
Float Shares:205.84M
Volume Ratio:0.73
T/O Rate:1.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7500
EPS(LYR):-1.3101
ROE:-96.44%
ROA:-49.48%
PB:1.49
PE(LYR):-0.44

Loading ...

Feb 25, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 25, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 20, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 20, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 11, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 11, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 11, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 10, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 04, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 30, 2026

Major Issues Report

Form 8-K - Current report
Jan 02, 2026

Major Issues Report

Form 8-K - Current report
Dec 12, 2025

Major Issues Report

Form 8-K - Current report
Dec 11, 2025

Major Issues Report

Form 8-K - Current report
Nov 10, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2025

Major Issues Report

Form 8-K - Current report
Nov 07, 2025

Major Issues Report

Form 8-K - Current report
Sep 05, 2025

Correspondence

Form CORRESP - Correspondence
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities